Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.

Condition:   End Stage Renal Disease Interventions:   Drug: 0.7% Xylitol, 0.5% Glucose, and 0.02% L-carnitine - or - 1.5% Xylitol, 0.5% Glucose, and 0.02% L-carnitine - or - 2.0% Xylitol, 1.5% Glucose, and 0.02% L-carnitine;   Drug: 1.36% or 2.27% or 3.86% Glucose Sponsor:   Iperboreal Pharma Srl Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials